Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

(2016) W. Ray Kim et al.   JOURNAL OF HEPATOLOGY

Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis

(2015) Takeji Umemura et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics

(2015) Hisashi Narimatsu   Expert Review of Proteomics

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

(2015) Masato Fujiyoshi et al.   JOURNAL OF GASTROENTEROLOGY

Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B

(2015) Jidong Jia et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

(2015) Hidenori Toyoda et al.   LIVER INTERNATIONAL

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

(2014) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

Antiviral therapy for chronic hepatitis B in China

(2014) Xin Zheng et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis

(2012) Wenwen Jin et al.   BMC GASTROENTEROLOGY

Clinical evidence for the regression of liver fibrosis

(2012) Elizabeth L. Ellis et al.   JOURNAL OF HEPATOLOGY

On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients

(2011) Grace Lai-Hung Wong et al.   ANTIVIRAL THERAPY

Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B

(2011) Sheng-di Wu et al.   Hepatology International

The HCV serum proteome: a search for fibrosis protein markers

(2009) K. J. Cheung et al.   JOURNAL OF VIRAL HEPATITIS

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

(2008) H. L.-Y. Chan et al.   JOURNAL OF VIRAL HEPATITIS